Trial Profile
Glutamine PET Imaging of Colorectal Cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 13 Mar 2024
Price :
$35
*
At a glance
- Drugs BAY 949392 (Primary) ; Glutamine
- Indications Colorectal cancer
- Focus Diagnostic use; Pharmacokinetics
- 06 Mar 2024 Status changed from recruiting to active, no longer recruiting.
- 04 Oct 2023 Planned End Date changed from 31 May 2025 to 30 Nov 2024.
- 27 Jul 2022 Planned End Date changed from 1 May 2025 to 31 May 2025.